Subsequent research endeavors have shed light on the role of Fgf2 in influencing tau protein phosphorylation, a process intimately tied to various neurodegenerative conditions, including Alzheimer’s disease (Scheltens et al. 2021). Here, MAPT is linked to Alzheimer disease.